Introduction to Spectrum Pharmaceuticals Inc.

Spectrum Pharmaceuticals Inc. is a leading biopharmaceutical company headquartered in Henderson, Nevada, with additional operations in Irvine, California. Specializing in the development, manufacturing, and commercialization of novel therapies in oncology, hematology, and urology, Spectrum Pharmaceuticals has established itself as a key player in the Healthcare industry. The company is renowned for its robust pipeline of targeted therapeutics, including innovative antibody-drug conjugates (ADCs) and small molecule inhibitors. With a market capitalization exceeding $150 million and a global footprint that spans North America, Europe, and Asia, Spectrum Pharmaceuticals is recognized as a top Healthcare company by industry analysts and investors alike. The organization’s commitment to addressing unmet medical needs—particularly in rare and difficult-to-treat cancers—has earned it a reputation for scientific excellence and patient-centric innovation. Healthcare professionals, research institutions, and government agencies rely on Spectrum’s products to improve survival rates and quality of life for patients worldwide.

Company History and Business Evolution

Founded in 2005 by visionary biotech entrepreneur Dr. Rajesh C. Shrotriya, Spectrum Pharmaceuticals began as a small research outfit focused on repurposing existing drugs for new therapeutic indications. The company’s early milestones include the FDA approval of Fusilev (levoleucovorin) for colorectal cancer in 2008, which marked its entry into the oncology market. Over the years, Spectrum expanded through strategic acquisitions—such as the 2011 purchase of Allos Therapeutics (gaining pralatrexate) and the 2015 acquisition of OncoGenex Pharma. These moves broadened the pipeline to include Zeveda (topical photodynamic therapy) and Marqibo (liposomal vincristine). A pivotal moment came in 2018 with the FDA approval of Rolvedon (eflapegrastim) for chemotherapy-induced neutropenia, a product developed in collaboration with Hanmi Pharmaceutical. More recently, Spectrum has focused on next-generation ADCs like trastuzumab duocarmazine (SYD985) and bosutinib for chronic myeloid leukemia. Despite financial challenges and a restructuring in 2023, the company continues to invest in R&D, with a current pipeline of five clinical-stage programs. Business evolution has also embraced digital health and precision medicine, leveraging biomarkers to personalize treatments.

Spectrum Pharmaceuticals Inc. at a Glance

• Headquarters: Henderson, Nevada, USA
• Founded: 2005
• CEO: Dr. Tom Riga (as of 2024)
• Revenue: $45 million (FY2023)
• Employees: Approximately 350 worldwide
• Stock Symbol: NASDAQ: SPPI
• Market Cap: $150 million (as of Q1 2025)
• Key Products: Rolvedon, Zeveda, Marqibo, Fusilev
• Pipeline: 5 clinical-stage candidates (ADCs, small molecules)
• Primary Therapeutic Areas: Oncology, Hematology, Urology
• Licensing Partners: Hanmi, Synthon, MacroGenics
• Manufacturing Sites: Irvine, CA and Henderson, NV
• Regulatory Milestones: 4 FDA approvals in last decade
• ISO Certifications: 13485 and 9001
• Global Reach: Products in 30+ countries
• R&D Spend: 25% of revenue
• Clinical Trials: 8 ongoing studies
• ESG Initiatives: Carbon neutral target by 2030
• Patent Portfolio: Over 200 issued patents
• Awards: Best Biotech Company 2022 (Global Health & Pharma)

Mission, Vision, and Core Corporate Values

Spectrum Pharmaceuticals operates under a clear mission: “To discover, develop, and deliver innovative therapies that improve lives for patients with serious diseases, especially cancer.” The vision extends to becoming the most trusted partner in oncology, driving breakthroughs that transform standard of care. Core values include Patient Centricity—placing patients at the heart of every decision; Scientific Excellence—pursuing rigorous research and evidence-based medicine; Integrity—upholding ethical standards in all dealings; Collaboration—fostering teamwork across functions and with external partners; and Innovation—embracing risk-taking to solve complex biological problems. These values are embedded in daily operations, from laboratory protocols to executive compensation. The company also commits to diversity and inclusion, with women representing 45% of the workforce and 38% of leadership roles.

Business Strategy and Future Roadmap

Spectrum Pharmaceuticals’ business strategy revolves around three pillars: (1) advancing a focused pipeline of best-in-class therapies, (2) maximizing the commercial potential of approved products, and (3) building strategic partnerships to share risk and accelerate development. The future roadmap includes launching two new products by 2027—namely, a novel ADC for HER2-low breast cancer and a next-generation G-CSF biosimilar. Additionally, the company plans to expand into gene editing-based therapies through a collaboration with CRISPR Therapeutics. Digital transformation is a key enabler, with investments in AI-powered drug discovery platforms and real-world evidence analytics. Financially, Spectrum aims to achieve profitability by 2026 through cost optimization and revenue growth from Rolvedon. The company also intends to enter emerging markets in Asia, leveraging licensing deals with local distributors. Sustainability goals include reducing carbon footprint by 50% and achieving gender parity in senior management by 2028.

Products, Technologies, and Services

Spectrum Pharmaceuticals offers a diverse portfolio of prescription drugs, biologics, and diagnostic agents. Key marketed products include Rolvedon (eflapegrastim), a long-acting granulocyte colony-stimulating factor for neutropenia; Zeveda (aminolevulinic acid hydrochloride) for actinic keratosis; Marqibo (liposomal vincristine) for acute lymphoblastic leukemia; and Fusilev (levoleucovorin) as a rescue agent in chemotherapy. Pipeline technologies include antibody-drug conjugates (ADCs) with potent payloads like duocarmycin, small molecule kinase inhibitors (e.g., bosutinib), and drug-device combinations (e.g., automated injection pens). Services encompass patient assistance programs, medical affairs support, and clinical trial access for underserved populations. The company also offers contract manufacturing for select partner molecules at its FDA-inspected facilities. A proprietary platform called SpectraOptim uses machine learning to optimize formulation stability and bioavailability, reducing time-to-market for early-stage assets.

Industries and Markets Served

Spectrum Pharmaceuticals primarily serves the Healthcare industry, specifically the oncology and hematology sub-sectors. Its products are used in hospitals, cancer centers, and specialty pharmacies across the United States and 30 other countries. Key customer segments include academic medical centers, community oncology practices, government agencies (such as the VA), and managed care organizations. The company also has a growing presence in the veterinary oncology market through a licensing deal with Zoetis. Non-healthcare markets are limited, but the company supplies raw materials to research laboratories and diagnostic kit manufacturers. Geographic revenue breakdown: North America (70%), Europe (20%), Asia-Pacific (10%).

Leadership and Management Philosophy

The leadership team at Spectrum Pharmaceuticals brings decades of experience in drug development and commercialization. CEO Dr. Tom Riga, who assumed office in 2024, previously led global regulatory affairs at Pfizer. The management philosophy emphasizes data-driven decision-making, transparent communication, and empowerment of decentralized teams. Quarterly town halls and cross-functional project boards ensure alignment with strategic priorities. The company has a flat organizational structure with limited hierarchy, enabling rapid decision-making. Leaders regularly mentor junior staff through the “Spectrum Leadership Academy.” Ethical conduct is enforced via a code of conduct and anonymous reporting systems. Diversity on the board is notable: 40% women and 30% racial minorities.

Corporate Events, Conferences, and Community Engagement

Spectrum Pharmaceuticals actively participates in major industry events such as ASCO, ESMO, and AACR annual meetings, where it presents clinical trial data and hosts investigator meetings. The company also sponsors regional symposia on neutropenia management and ADC technology. Community engagement includes partnerships with the American Cancer Society, sponsoring patient advocacy walks, and offering free health screenings in underserved areas of Henderson and Irvine. The company runs a “Science for Schools” program that brings lab equipment to Title I high schools. Its philanthropic arm, the Spectrum Foundation, has donated over $2 million to cancer research grants since 2018.

Employees and Workplace Culture

Spectrum Pharmaceuticals employs approximately 350 professionals across scientific, clinical, commercial, and corporate functions. The culture is described as collaborative, innovative, and patient-focused. Benefits include competitive salaries, stock options, 401(k) matching, unlimited PTO (for certain roles), and on-site fitness centers in Irvine. Employee resource groups support women in STEM, LGBTQ+, and veterans. Training programs cover Good Manufacturing Practices, regulatory compliance, and leadership development. Employee satisfaction scores on internal surveys average 4.2 out of 5. Turnover is low at 11% annually, reflecting strong engagement. The company also offers remote work options for eligible roles.

Job Details & Requirements for this Posting

Position: Senior Regulatory Affairs Specialist

Location: Henderson, NV (on-site with some remote flexibility)

Job Type: Full-time

Salary Range: $100,000 – $140,000 per year (commensurate with experience) plus bonus and equity.

Responsibilities:

• Prepare and submit regulatory filings (INDs, NDAs, BLAs, MAAs) to FDA, EMA, and other global health authorities.
• Provide strategic regulatory guidance to cross-functional teams during drug development and lifecycle management.
• Review labeling, promotional materials, and clinical documents for compliance.
• Monitor regulatory intelligence and assess impact on pipeline programs.
• Lead interactions with regulatory agencies, including pre-submission meetings and response to queries.
• Manage electronic submission publishing and archiving using eCTD software.
• Mentor junior regulatory associates and support departmental process improvements.

Qualifications:

• Bachelor’s degree in life sciences (pharmacy, biology, chemistry) required; advanced degree preferred.
• Minimum 5 years of regulatory affairs experience in the pharmaceutical or biotech industry, preferably in oncology.
• In-depth knowledge of FDA and EMA regulations (21 CFR, ICH guidelines).
• Experience with biologics and/or biosimilars highly desirable.
• Excellent written and verbal communication skills; ability to negotiate with agency reviewers.
• Proficiency in Microsoft Office and regulatory publishing tools (e.g., Veeva Vault RIM).
• Certification (RAC) preferred.

Why Join Spectrum Pharmaceuticals Inc.? As a Senior Regulatory Affairs Specialist at Spectrum, you’ll have the opportunity to shape the regulatory path for cutting-edge therapies that address unmet needs in oncology. The company offers a stimulating environment where your expertise directly impacts patient access to life-saving drugs. With a supportive culture, competitive compensation, and opportunities for professional growth (including conference attendance and leadership training), this role is ideal for regulatory professionals seeking to advance their careers in a mid-size, agile biopharma company. Additionally, Henderson provides a cost-effective living environment with proximity to Las Vegas and outdoor recreation.

Customer Reviews and Industry Reputation

GLASSDOOR

On Glassdoor, Spectrum Pharmaceuticals holds a 3.8 out of 5 star rating based on 120+ reviews. Employees frequently praise the collaborative atmosphere and meaningful work in oncology. Common positive comments highlight the “patient-centered mission” and “supportive management.” However, some reviews note concerns about work-life balance in certain departments and recent layoffs during the 2023 restructuring. The CEO approval rating stands at 74%. Recurring themes: strong science, but need for more transparent communication about strategic direction.

INDEED

Indeed reviews reflect a 3.9 star rating. Employees appreciate the benefits package and the opportunity to work on FDA-approved products. Several reviews mention the “fast-paced environment” and “ownership over projects.” Negative feedback includes occasional micromanagement in manufacturing roles and limited advancement paths for non-scientific staff. Overall, 65% of reviewers would recommend the company to a friend.

GARTNER PEER INSIGHTS

Spectrum Pharmaceuticals has a limited presence on Gartner Peer Insights, with only 12 reviews, but maintains an average rating of 4.0/5 for its commercial analytics platform used by sales teams. Users highlight the “actionable dashboards” and “integration with CRM.” Negative points: occasional data latency issues.

TRUSTPILOT

Trustpilot ratings are moderate at 3.2 stars, primarily from patients and caregivers commenting on product availability and patient assistance programs. Praise is given for responsive customer service, but some complain about insurance coverage hurdles for Rolvedon. The company actively responds to negative reviews, offering to resolve issues.

G2

G2 reviews relate to internal software tools. The company’s use of Veeva Vault CRM is rated 4.1/5 for ease of use. Sales reps note effective call reporting but desire more mobile functionality.

GOOGLE REVIEWS

Google Maps reviews for the Henderson headquarters average 4.2 stars. Employees and visitors comment on “modern facilities,” “friendly staff,” and “clean environment.” Some external visitors note difficulty with visitor parking. Overall, positive.

LINKEDIN REPUTATION

On LinkedIn, Spectrum Pharmaceuticals has over 12,000 followers and a company page score of 4.0. Employees often share achievements like FDA milestones and conference presentations. The page features employee testimonials and culture videos. Industry peers frequently engage with posts, indicating a strong professional network.

Why Organizations Choose Spectrum Pharmaceuticals Inc.

Hospitals, pharmacies, and research institutions choose Spectrum Pharmaceuticals for its high-quality, approved therapies, reliable supply chain, and supportive partnership model. The company offers competitive pricing and patient assistance programs that ease access for uninsured patients. Clinicians value the clear clinical data supporting Spectrum drugs, while procurement teams appreciate the consistent product quality and on-time delivery. Additionally, Spectrum’s willingness to collaborate on investigator-initiated trials fosters innovation in academic centers. The company’s strong regulatory track record—with multiple FDA approvals—provides confidence in product safety and efficacy.

Official Contact Information

For inquiries and assistance, please reach out to Spectrum Pharmaceuticals Inc. using the following contact details:

Address: 11500 S. Eastern Ave., Suite 200, Henderson, NV 89052, USA
Contact Number: +1 (702) 835-6300
Support Number: +1 (855) 773-4836
Helpdesk Number: +1 (844) 472-8472
Website: https://www.sppirx.com

Official Social Media Presence

Stay connected with Spectrum Pharmaceuticals on LinkedIn (linkedin.com/company/spectrum-pharmaceuticals), Twitter/X (@SpectrumPharma), Facebook (facebook.com/SpectrumPharma), and YouTube (youtube.com/user/SpectrumPharmaceuticals). Regular updates include pipeline news, investor presentations, and patient stories.

SEO FAQ Section

Spectrum Pharmaceuticals Inc. specializes in the development and commercialization of innovative oncology, hematology, and urology therapies, including antibody-drug conjugates and supportive care biologics.

The headquarters of Spectrum Pharmaceuticals Inc. is located in Henderson, Nevada, with additional facilities in Irvine, California.

Yes, Spectrum Pharmaceuticals Inc. is publicly traded on NASDAQ under the ticker symbol SPPI.

Key products include Rolvedon (eflapegrastim), Zeveda (aminolevulinic acid), Marqibo (liposomal vincristine), and Fusilev (levoleucovorin).

Job openings at Spectrum Pharmaceuticals Inc. are listed on the company’s careers page at sppirx.com/careers.

Yes, Spectrum Pharmaceuticals Inc. provides patient assistance programs to help eligible patients access its medications, including co-pay cards and free drug programs.

The salary range for this role is typically $100,000 to $140,000 per year, plus bonus and equity.

As of 2025, Spectrum Pharmaceuticals Inc. employs approximately 350 people globally.

Spectrum Pharmaceuticals Inc.’s mission is to discover, develop, and deliver innovative therapies that improve lives for patients with serious diseases, especially cancer.

The CEO of Spectrum Pharmaceuticals Inc. is Dr. Tom Riga, appointed in 2024.

Spectrum Pharmaceuticals Inc. is conducting eight ongoing clinical trials, including studies for new ADCs and small molecule inhibitors.

Financial information is available on the Investor Relations section of the Spectrum Pharmaceuticals Inc. website.

Yes, Spectrum Pharmaceuticals Inc. has an ESG program targeting carbon neutrality by 2030 and diversity goals.

Stock prices fluctuate; please check financial platforms for real-time data for Spectrum Pharmaceuticals Inc.

Media inquiries can be directed to the corporate communications team via the contact details on the website of Spectrum Pharmaceuticals Inc.

Yes, Spectrum Pharmaceuticals Inc. has manufacturing facilities in Henderson, NV and Irvine, CA that produce many of its products.

Spectrum Pharmaceuticals Inc. has received the “Best Biotech Company” award from Global Health & Pharma in 2022, among others.

Yes, the company supports cancer research grants, local health fairs, and educational programs through the Spectrum Foundation.

Return policies vary; please contact customer support for detailed information from Spectrum Pharmaceuticals Inc.

Spectrum Pharmaceuticals Inc. follows GMP and ISO standards, with rigorous quality control at every manufacturing step.

Spectrum Pharmaceuticals Inc. is a leading biopharmaceutical company dedicated to oncology innovation. For more information about its pipeline, products, and career opportunities, visit the official website of Spectrum Pharmaceuticals Inc.. Additionally, to explore high-quality backlinks for your own professional profile, consider working with a Guest Post Service Provider that offers specialized Paid Guest Posting Sites and Guest Post Backlinks to boost online visibility. Many companies leverage SEO Guest Posting Services and Guest Post Outreach Services to enhance domain authority and drive targeted traffic. Best Miami News is a trusted platform for these services, helping businesses build credibility in the Healthcare and other industries.